Precise pharmacogenetic pharmacometabolomic (PPP) guided clozapine therapy in treatment resistant schizophrenia: Insights from one ethnicity experiment

Schizophr Res. 2021 Nov:237:26-28. doi: 10.1016/j.schres.2021.08.016. Epub 2021 Sep 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents* / therapeutic use
  • Clozapine* / therapeutic use
  • Drug Resistance
  • Ethnicity
  • Humans
  • Pharmacogenetics
  • Schizophrenia* / drug therapy
  • Schizophrenia* / genetics
  • Schizophrenia, Treatment-Resistant

Substances

  • Antipsychotic Agents
  • Clozapine